Phase XII, group 3 - 01.07.2016 - 30.06.2019

Ca.-No 170

Mechanisms supporting hepatic ectopic lymphoid-like structures (ELS) development and egression of ELS-resident tumor progenitors

Israeli Partner: E. Pikarsky, Hebrew University
German Partner: M. Heikenwälder, DKFZ

Publications

2019 - Nature reviews / Gastroenterology & hepatology Gastroenterology & hepatology [...]

Ca.-No 171

Delinaeting the role of the long noncoding RNA TP73-AS1 in medulloblastoma

Israeli Partner: B. Rotblat, Ben-Gurion University
German Partner: M. Remke, DKFZ, DKTK Univ. Hospital Düsseldorf

Ca.-No 172

Potentiating immunotherapy of cancer by harnessing natural killer cell receptors

Israeli Partner: A. Porgador, Ben-Gurion University
German Partner: A. Cerwenka, DKFZ

Publications

Ca.-No 173

An integrated experimental-computational study of metabolic adaptions underlying antifolate resistance in cancer and their targeting via synthetic lethality

Israeli Partner: T. Shlomi, Technion
German Partner: J. Hoheisel, DKFZ

Ca.-No 174

Studying T cell diversification using single cell experiments and mathematical modelling – towards rational design of anti-tumor T cell responses

Israeli Partner: N. Friedman, Weizmann Institute
German Partner: T. Höfer, DKFZ

Ca.-No 175

Analysis of regulatory pathways leading alternative splicing aberrations in CNS ependymoma and breast cancer

Israeli Partner: G. Ast, Tel Aviv University
German Partner: A. Hotz-Wagenblatt, M. Kool, DKFZ

Formular

Formulardaten werden geladen ...